4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2
The NM_001388492.1(HTT):c.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA(p.Gln30_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0070 ( 4 hom., cov: 0)
Exomes 𝑓: 0.0026 ( 41 hom. )
Consequence
HTT
NM_001388492.1 disruptive_inframe_insertion
NM_001388492.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.84
Publications
6 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3779750.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00701 (924/131880) while in subpopulation AMR AF = 0.00843 (113/13412). AF 95% confidence interval is 0.00754. There are 4 homozygotes in GnomAd4. There are 431 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTT | NM_001388492.1 | c.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA | p.Gln30_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | ENST00000355072.11 | NP_001375421.1 | |
HTT | NM_002111.8 | c.87_110dupGCAGCAGCAGCAGCAGCAGCAGCA | p.Gln30_Gln37dup | disruptive_inframe_insertion | Exon 1 of 67 | NP_002102.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00702 AC: 925AN: 131782Hom.: 4 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
925
AN:
131782
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00259 AC: 3174AN: 1225730Hom.: 41 Cov.: 0 AF XY: 0.00271 AC XY: 1646AN XY: 608074 show subpopulations
GnomAD4 exome
AF:
AC:
3174
AN:
1225730
Hom.:
Cov.:
0
AF XY:
AC XY:
1646
AN XY:
608074
show subpopulations
African (AFR)
AF:
AC:
58
AN:
25808
American (AMR)
AF:
AC:
116
AN:
30300
Ashkenazi Jewish (ASJ)
AF:
AC:
66
AN:
22730
East Asian (EAS)
AF:
AC:
51
AN:
29096
South Asian (SAS)
AF:
AC:
225
AN:
72224
European-Finnish (FIN)
AF:
AC:
148
AN:
32498
Middle Eastern (MID)
AF:
AC:
16
AN:
3784
European-Non Finnish (NFE)
AF:
AC:
2293
AN:
957466
Other (OTH)
AF:
AC:
201
AN:
51824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
98
196
293
391
489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00701 AC: 924AN: 131880Hom.: 4 Cov.: 0 AF XY: 0.00680 AC XY: 431AN XY: 63424 show subpopulations
GnomAD4 genome
AF:
AC:
924
AN:
131880
Hom.:
Cov.:
0
AF XY:
AC XY:
431
AN XY:
63424
show subpopulations
African (AFR)
AF:
AC:
217
AN:
35526
American (AMR)
AF:
AC:
113
AN:
13412
Ashkenazi Jewish (ASJ)
AF:
AC:
17
AN:
3190
East Asian (EAS)
AF:
AC:
7
AN:
4124
South Asian (SAS)
AF:
AC:
18
AN:
3910
European-Finnish (FIN)
AF:
AC:
29
AN:
7368
Middle Eastern (MID)
AF:
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
AC:
500
AN:
61482
Other (OTH)
AF:
AC:
17
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Huntington disease Uncertain:1
Jan 22, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research
- -
not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.